Unlocking the Future of pharmacogenomics technology theranostics companion diagnostics cdx: Growth and Trends 2026-2034

The pharmacogenomics, theranostics, and companion diagnostics (CDx) market is booming, driven by personalized medicine and advanced genomic technologies. Learn about market size, growth trends, key players (Qiagen, Roche, Thermo Fisher), and regional insights for this rapidly expanding sector. Discover how this technology is revolutionizing healthcare and improving patient outcomes.


Total Amount: $0
$6800.00
$5100.00
$3400.00

Our Clients

No payment methods available.

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Key Highlights of Report

Jul, 2025
93
Tables
Base Year: 2025.
Coverage: 18 Countries
Companies: 15+

Connect With Us


avatar

Craig Francis

Head Of Sales

Email: [email protected]

+17162654855